Chloramphenicol succinate is an ester prodrug of [chloramphenicol]. Chloramphenicol is a bacteriostatic antibiotic. Use of chloramphenicol succinate and chloramphenicol has decreased due to the risk of potentially fatal blood dyscrasias. Chloramphenicol succinate was granted FDA approval on 20 February 1959. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Chronicin foam, Levomycetin succinate, Chloromycetin succinate and Kemicetine succinate. Its PubChem CID is 656580.
Chloramphenicol succinate
| CAS No | 3544-94-3 |
|---|---|
| Molecular Formula | C15H16Cl2N2O8 |
| Molecular Weight | 423.2 g/mol |
| Synonyms | 4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Chloramphenicol succinate is an ester prodrug of [chloramphenicol]. Chloramphenicol is a bacteriostatic antibiotic. Use of chloramphenicol succinate and chloramphenicol has decreased due to the risk of potentially fatal blood dyscrasias.
The listed CAS number is 3544-94-3.
The listed molecular formula is C15H16Cl2N2O8.
The listed molecular weight is 423.2 g/mol.
4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid.
The source lists Chronicin foam, Levomycetin succinate, Chloromycetin succinate and Kemicetine succinate.